These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 2862789)

  • 1. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas.
    Barber GB; Lee DE; Antonioli DA; Peppercorn MA
    Am J Gastroenterol; 1985 Aug; 80(8):612-4. PubMed ID: 2862789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.
    Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ
    Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
    Kam L; Cohen H; Dooley C; Rubin P; Orchard J
    Am J Gastroenterol; 1996 Jul; 91(7):1338-42. PubMed ID: 8677990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: long-term results.
    Guarino J; Chatzinoff M; Berk T; Friedman LS
    Am J Gastroenterol; 1987 Aug; 82(8):732-7. PubMed ID: 3496786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW; Gales BJ
    Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfasalazine and 5-ASA compounds.
    Allgayer H
    Gastroenterol Clin North Am; 1992 Sep; 21(3):643-58. PubMed ID: 1355468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
    Baker DE; Kane S
    Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
    Andreoli A; Spinella S; Levenstein S; Prantera C
    Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM; Greenberg GR
    Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical salicylate therapy (4-ASA and 5-ASA enemas).
    Ginsberg AL
    Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
    Marshall JK; Irvine EJ
    Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Aminosalicylic acid enemas in patients with active ulcerative colitis. Influence of acidity on the kinetic pattern.
    Bondesen S; Nielsen OH; Jacobsen O; Rasmussen SN; Hansen SH; Halskov S; Binder V; Hvidberg EF
    Scand J Gastroenterol; 1984 Jul; 19(5):677-82. PubMed ID: 6382570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema.
    Gionchetti P; Belluzzi A; Campieri M; Torresan F; Tabanelli GM; Brignola C; Miglioli M; Barbara L
    Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):667-9. PubMed ID: 3236941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.
    D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New salicylate therapies for ulcerative colitis.
    Bruckstein AH
    Postgrad Med; 1990 Sep; 88(3):79-82, 84, 89. PubMed ID: 1975952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conservative therapy of ulcerative colitis and Crohn disease].
    Rasenack J; Kreisel W
    Fortschr Med; 1991 Apr; 109(11):245-7. PubMed ID: 1855750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-ASA enema therapy.
    Hanauer SB
    Neth J Med; 1989 Jun; 35 Suppl 1():S11-20. PubMed ID: 2702307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral mesalamine for ulcerative colitis.
    Med Lett Drugs Ther; 1992 Aug; 34(877):80-1. PubMed ID: 1353858
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
    Sandborn WJ
    Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.